A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer
A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer
Active, not recruiting · NCT07777211 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-20 | NCT07777211 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Gene Key Life Technology Co., Ltd | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No. 1 Shuaifuyuan, Wangfujing, Dongcheng District | Beijing | China | 1 |